Neuraxis, Inc. Common Stock
Key Metrics
Market Snapshot
About
NeurAxis, Inc. (NRXS) is a medical technology company based in Carmel, Indiana, focused on developing neuromodulation therapies for chronic conditions in both pediatric and adult patients.
The company's core commercial product is the IB-Stim system, a percutaneous electrical nerve field stimulator. This device is cleared for use in patients aged eight and older to address symptoms associated with functional gastrointestinal disorders, including abdominal pain from irritable bowel syndrome and nausea from functional dyspepsia. Its therapeutic approach involves using gentle electrical stimulation to target specific nerves. NeurAxis also offers a rectal expulsion device, which serves as a diagnostic screening tool for identifying evacuation disorders in patients.
NeurAxis sells its medical devices primarily to healthcare providers within hospitals and clinical settings. Founded in 2011 and originally named Innovative Health Solutions, the company rebranded to NeurAxis, Inc. in March 2022. Its ongoing business strategy centers on advancing its neuromodulation platform to treat a range of debilitating conditions where traditional medical management may be insufficient.